Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Advanced Breast Cancer × Gemcitabine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pancreatic Neoplasms 294 Carcinoma, Non-Small-Cell Lung 159 Lung Neoplasms 88 Breast Neoplasms 84 Urinary Bladder Neoplasms 82 Cholangiocarcinoma 57 Neoplasms 52 Neoplasm Metastasis 51 Ovarian Neoplasms 45 Biliary Tract Neoplasms 43 Lymphoma, Large B-Cell, Diffuse 31 Lymphoma 30 Sarcoma 29 Hodgkin Disease 28 Recurrence 26 Nasopharyngeal Carcinoma 26 Gallbladder Neoplasms 26 Carcinoma, Transitional Cell 26 Adenocarcinoma 22 Triple Negative Breast Neoplasms 20 Fallopian Tube Neoplasms 20 Bile Duct Neoplasms 20 Adenocarcinoma of Lung 20 Carcinoma, Renal Cell 17 Carcinoma, Ovarian Epithelial 16 Urethral Neoplasms 15 Lymphoma, Non-Hodgkin 14 Colorectal Neoplasms 14 Leiomyosarcoma 13 Kidney Neoplasms 13

Interventions

Fulvestrant 8 olaparib 4 Capecitabine 4 pyrotinib 3 Docetaxel 3 Vinorelbine 2 Trastuzumab 2 Letrozole 2 Alpelisib 2 vandetanib 1 trastuzumab deruxtecan 1 talazoparib 1 sacituzumab govitecan 1 pembrolizumab 1 neratinib 1 liposomal doxorubicin 1 exemestane 1 eribulin 1 dalpiciclib 1 ceralasertib 1 cediranib 1 capivasertib 1 abemaciclib 1 Tablets 1 Moxifloxacin 1 Injections 1 Goserelin 1 Gemcitabine 1 Everolimus 1 Dasatinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03025880 2023-04-03

PANGEA

Spanish Breast Cancer Research Group

Phase 2 Completed

36 enrolled 28 charts

Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡